Compounds > 2,3-dinor-thromboxane b2

2,3-dinor-thromboxane b2 and Smoking Cessation

2,3-dinor-thromboxane b2 has been researched along with Smoking Cessation in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gregg, EO; Lowe, FJ; McEwan, M1
Benthin, G; Granström, EF; Persson, L; Rångemark, C; Wennmalm, A; Winell, S1

Other Studies

2 other study(ies) available for 2,3-dinor-thromboxane b2 and Smoking Cessation

ArticleYear
Evaluation of biomarkers of exposure and potential harm in smokers, former smokers and never-smokers.
    Clinical chemistry and laboratory medicine, 2009, Volume: 47, Issue:3

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Aged; Biomarkers; Cholesterol, LDL; Cross-Sectional Studies; Deoxyguanosine; Dinoprost; Female; Humans; Immunoglobulin G; Male; Middle Aged; Nicotine; Nitrosamines; Pyridines; Reproducibility of Results; Smoke; Smoking; Smoking Cessation; Thromboxane B2; Thymidine

2009
Tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in women stratified by age.
    Circulation, 1992, Volume: 86, Issue:5

    Topics: 6-Ketoprostaglandin F1 alpha; Adult; Age Factors; Cardiovascular Diseases; Female; Gas Chromatography-Mass Spectrometry; Humans; Middle Aged; Platelet Activation; Risk Factors; Smoking; Smoking Cessation; Thromboxane B2

1992